---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-007384"
form_type: "8-K"
ticker: "CBDW"
cik: "0001877461"
company_name: "1606 CORP."
filed_at: "2024-11-19T23:59:59+00:00"
generated_at: "2026-05-29T22:40:18.330824+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "medium"
source: SEC EDGAR
---

# 1606 Corp. files Q3 10-Q, signs LOI with Adnexus Biotechnologies

## Summary
- Filed Q3 10-Q for period ended September 30, 2024, maintaining continuous quarterly filings since inception.
- Signed Letter of Intent with Adnexus Biotechnologies for a potential strategic investment in AI and biotech.
- No financial metrics reported; press release focuses on narrative progress and forward-looking outlook.
- CEO plans to close Adnexus investment and expand AI chatbot solutions into healthcare, finance, and telecom.

## SEC filing metadata
- accession: 0001477932-24-007384
- form_type: 8-K
- ticker: CBDW
- cik: 0001877461
- company_name: 1606 CORP.
- filed_at: 2024-11-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1877461/000147793224007384/0001477932-24-007384-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1877461/000147793224007384/onesix_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-007384
- JSON: https://secwatch.observer/filing/0001477932-24-007384.json
- Plain text: https://secwatch.observer/filing/0001477932-24-007384.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.